Skip to main content
Medtronic plc logo

Medtronic plc — Investor Relations & Filings

Ticker · MDT ISIN · US58446C1036 LEI · D56MRZY2INAN94ZONZ37 US Manufacturing
Open in API
Filings indexed 1,143 across all filing types
Latest filing 2017-10-26 Annual Report
Country US United States of America
Listing US MDT

About Medtronic plc

https://www.medtronic.com/

Medtronic plc is a global healthcare technology company that develops, manufactures, and sells device-based medical therapies and solutions. The company's portfolio addresses more than 70 health conditions, primarily organized into four key areas: Cardiovascular, Medical Surgical, Neuroscience, and Diabetes. Its products range from pacemakers and neurovascular care devices to insulin pumps and systems for robotic-assisted surgery. Medtronic's technologies are designed to be used by healthcare systems, physicians, clinicians, and patients to alleviate pain, restore health, and extend life.

Recent filings

Filing Released Lang Actions
11-K
Annual Report Classification · 95% confidence The document is titled 'FORM 11-K' and is an annual report pursuant to Section 15(d) of the Securities Exchange Act of 1934 for the fiscal year ended April 30, 2017. It contains detailed financial statements of the Medtronic Savings and Investment Plan (also known as the Medtronic 401(k) Plan), including statements of net assets available for benefits, changes in net assets, notes to financial statements, and an independent auditor's report. The content is consistent with the requirements of Form 11-K, which is an annual report for employee benefit plans filed with the SEC. The document is substantive, contains actual financial data, and is not merely an announcement or certification. Therefore, the appropriate classification is 'Annual Report' with the specific code '10-K' as per the filing definitions provided, since Form 11-K is a type of annual report for employee benefit plans.
2017-10-26 English
Regulatory Filings 2017
Regulatory Filings
2017-10-26 English
MEDTRONIC PLC - DEFA14A
Proxy Solicitation & Information Statement Classification · 100% confidence The document is a Schedule 14A Proxy Statement filed with the SEC, which is used to provide shareholders with information to vote on matters at the Annual General Meeting (AGM). It includes details about the meeting date, location, voting instructions, election of directors, auditor ratification, executive compensation vote, and stock plan amendments. The document is not the actual Annual Report or financial statements but rather proxy materials related to governance and shareholder voting. Therefore, it fits the category of Proxy Solicitation & Information Statement (PSI). The document length (6663 characters) and content confirm it is a proxy statement, not a report publication announcement or other filing type.
2017-10-24 English
PRIMARY DOCUMENT
Director's Dealing
2017-10-16 English
MEDTRONIC PLC - DEFR14A
Proxy Solicitation & Information Statement Classification · 100% confidence The document is a Schedule 14A proxy statement filed with the SEC, specifically a Definitive Proxy Statement for Medtronic plc's 2017 Annual General Meeting of Shareholders. It includes detailed information about the meeting agenda, director nominations, executive compensation, auditor ratification, and shareholder voting instructions. The document is not the annual report itself but a proxy solicitation document intended to inform shareholders and solicit their votes on various proposals at the AGM. The presence of detailed executive compensation discussion and director election information aligns with the characteristics of a proxy statement. Therefore, the document fits the category of Proxy Solicitation & Information Statement (PSI).
2017-10-11 English
Regulatory Filings 2017
Regulatory Filings Classification · 95% confidence The document is a letter from Medtronic plc to the SEC responding to comments on their previously filed Form 10-K for the fiscal year ended April 28, 2017. It addresses specific inquiries about business dealings in sanctioned countries, materiality of those dealings, tax disclosures, and divestiture accounting. The letter references the 10-K filing and provides clarifications and commitments for future filings but does not itself contain the full annual report or financial statements. It is a regulatory correspondence responding to SEC staff comments, which fits the category of Regulatory Filings (RNS) rather than the actual 10-K report or other financial filings.
2017-10-10 English

Browse filings by year

15 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.